We have continued to focus on the role of insulin-like growth factors (IGF's) and tumor specific translocations in the pathogenesis of pediatric sarcomas, specifically rhabdomyosarcomas (RMS), Ewing's sarcomas/PNET (Ewing's family of tumors EFT), and osteogenic sarcomas (OS). We have recently completed a randomized study of GH-IGF-I inhibition using a somatostatin analog in dogs with osteosarcomas. We hypothesized that lowering IGF-I levels would lead to increased apoptosis in tumor cells treated with standard chemotherapy. Forty-six dogs were randomized on this study and the data are currently being analyzed. Preliminary analysis reveals that treatment with no the somatostatin analog led to a 50% decrease in circulating IGF-I levels and no increase in survival. Utilizing cDNA micro-array analysis, we have compared the expression profiles in 3T3 fibroblasts overexpressing IGF-I receptors following ligand stimulation to profiles in 3T3 cells overexpressing insulin receptors following ligand stimulation. In general, IGF-I receptor stimulation leads to more changes in growth and differentiation gene expression, while insulin receptor stimulation leads to changes in metabolic pathways. We found that the oncogene twist was upregulated by IGF-I receptor stimulation and this appears to help mediate the anti-apoptotic signaling of IGF-I. We have continued to utilize C2 mouse myoblasts overexpressing IGF2 to determine specific consequences of IGF2 overexpression in a muscle background. We have found that IGF-II induced resistance to apoptosis is mediated in part through a PI3K-AKT-p70S6K pathway with p70S6K being the most distal component. This is reversed by rapamycin, and we are exploring possible clinical applications of this drug in treatment of pediatric sarcomas with activated PI3K-AKT-p70S6K pathways. We are currently focusing on the role of FKHR in mediating IGF related anti-apoptotic events as well, since this gene is altered in the t(2;13) translocation in alveolar rhabdomyosarcoma and appears to be an important signal in this pathway. We are continuing to collaborate on a genetic model of rhabdomyosarcoma in mice, and have found that this model predicts abnormalities in the p16-CDK-4-cylcin D-Rb pathway in these tumors and have confirmed such abnormalities in human tumor specimens. We have used cDNA microarray analysis to identify genetic determinants of metastasis in an established mouse orthotopic model of osteosarcoma with spontaneous metastases. . One gene identified that appears to be highly correlated with metastatic behavior is ezrin, a member of the ezrin-radixin-moesin family of proteinsthat function as plasma membrane-cytoskeletal linkers. Preliminary functional data support the role of this protein in metastatic behavior in osteosarcoma.

Agency
National Institute of Health (NIH)
Institute
Division of Clinical Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01SC006892-13
Application #
6558384
Study Section
(POB)
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Clinical Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Kim, Su Young; Lee, Chih Hung; Midura, Brieanne V et al. (2008) Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clin Exp Metastasis 25:201-11
Mackall, Crystal L; Rhee, Eunice H; Read, Elizabeth J et al. (2008) A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas. Clin Cancer Res 14:4850-8
Wan, X; Harkavy, B; Shen, N et al. (2007) Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene 26:1932-40
Petricoin 3rd, Emanuel F; Espina, Virginia; Araujo, Robyn P et al. (2007) Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival. Cancer Res 67:3431-40
Merchant, Melinda S; Melchionda, Fraia; Sinha, Manoj et al. (2007) Immune reconstitution prevents metastatic recurrence of murine osteosarcoma. Cancer Immunol Immunother 56:1037-46
van den Broeke, Leon T; Pendleton, C David; Mackall, Crystal et al. (2006) Identification and epitope enhancement of a PAX-FKHR fusion protein breakpoint epitope in alveolar rhabdomyosarcoma cells created by a tumorigenic chromosomal translocation inducing CTL capable of lysing human tumors. Cancer Res 66:1818-23
Wan, Xiaolin; Shen, Na; Mendoza, Arnulfo et al. (2006) CCI-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1alpha/VEGF signaling. Neoplasia 8:394-401
Terabe, Masaki; Khanna, Chand; Bose, Seuli et al. (2006) CD1d-restricted natural killer T cells can down-regulate tumor immunosurveillance independent of interleukin-4 receptor-signal transducer and activator of transcription 6 or transforming growth factor-beta. Cancer Res 66:3869-75
Krishnan, Kartik; Khanna, Chand; Helman, Lee J (2006) The molecular biology of pulmonary metastasis. Thorac Surg Clin 16:115-24
Khanna, Chand; Helman, Lee J (2006) Molecular approaches in pediatric oncology. Annu Rev Med 57:83-97

Showing the most recent 10 out of 19 publications